A Phase IB Study to Use Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
Latest Information Update: 15 Jun 2023
At a glance
- Drugs Tadalafil (Primary) ; Temozolomide
- Indications Astrocytoma; Gliosarcoma
- Focus Adverse reactions; Therapeutic Use
- 12 Jun 2023 Status changed from active, no longer recruiting to completed.
- 09 Jun 2022 Planned End Date changed from 31 Jul 2023 to 3 Jun 2023.
- 09 Jun 2022 Planned primary completion date changed from 31 Jul 2023 to 3 Jun 2023.